SC rejects Novartis plea on cancer drug patent
Updated on Apr 01, 2013 01:16 pm IST
The Supreme Court on Monday rejected a plea by Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India. The patents would be granted only for genuine inventions, cited the Supreme Court, a decision that paves way for Indian companies to manufacture generic drugs for cancer.
RELATED VIDEOS
Watch: PM Nehru's last-ever Independence Day speech | 1963
Published on Aug 01, 2026 08:22 pm IST
1948 Independence Day speech: What Nehru said on religious hate on 1st I-Day
Published on Jul 31, 2026 05:13 pm IST
Israel’s UN envoy tries to turn Mamdani into the enemy?
Published on Jul 29, 2026 08:25 pm IST
New anti-exam paper leak bill in parliament: minister lists measures
Published on Jul 28, 2026 05:14 pm IST
From Rahul Gandhi to Arvind Kejriwal: Opposition leaders salute youth
Published on Jul 25, 2026 05:41 pm IST
Dharmendra Pradhan resigns as NEET leak protests hit boiling point
Published on Jul 25, 2026 04:15 pm IST
Hi, {{name}}
Sign out
{{planName}}
{{^userSubscribed}}
{{/userSubscribed}}